Literature DB >> 16279257

Factorial designs: a graphical aid for choosing study designs accounting for interaction.

Karen Byth1, Val Gebski.   

Abstract

The presence of possible treatment interaction when designing a factorial study can be either greeted with dismay (for an antagonistic or negative interaction) or can be welcome (in the case of a synergistic effect). The type of potential interaction may greatly influence the choice of study design. Depending on the magnitude of an expected additive or multiplicative interaction, a three-arm study, instead of a 2 x 2 factorial, may yield greater statistical power. A graphical aid for examining the loss of power due to the presence of such interaction is developed. The technique can also be applied to designing studies where prespecified subgroup analyses are of particular interest. Tests for interaction effects between subgroups are usually underpowered, even if the subgroups have been prespecified in the protocol. The technique can be used to determine the appropriate sample sizes in the subgroups to ensure adequate power to detect potential interaction effects. The method is illustrated with respect to a published 2 x 2 factorial study. In this study, interaction reduced the power of the final analysis to detect significant main effects.

Entities:  

Mesh:

Year:  2004        PMID: 16279257     DOI: 10.1191/1740774504cn026oa

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  10 in total

1.  Design and implementation of a factorial randomized controlled trial of methadone maintenance therapy and an evidence-based behavioral intervention for incarcerated people living with HIV and opioid dependence in Malaysia.

Authors:  Alexander R Bazazi; Jeffrey A Wickersham; Martin P Wegman; Gabriel J Culbert; Veena Pillai; Roman Shrestha; Haider Al-Darraji; Michael M Copenhaver; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Contemp Clin Trials       Date:  2017-05-04       Impact factor: 2.226

2.  Etoricoxib--preemptive and postoperative analgesia (EPPA) in patients with laparotomy or thoracotomy--design and protocols.

Authors:  Johannes Fleckenstein; Sybille Kramer; Martin Offenbächer; Gabriel Schober; Herbert Plischke; Matthias Siebeck; Thomas Mussack; Rudolf Hatz; Lukas Lehmeyer; Philip M Lang; Bernhard Heindl; Peter Conzen; Dominik Irnich
Journal:  Trials       Date:  2010-05-27       Impact factor: 2.279

3.  Comparison of a phased experimental approach and a single randomized clinical trial for developing multicomponent behavioral interventions.

Authors:  Linda M Collins; Bibhas Chakraborty; Susan A Murphy; Victor Strecher
Journal:  Clin Trials       Date:  2009-02       Impact factor: 2.486

Review 4.  Ethical and scientific considerations for patient enrollment into concurrent clinical trials.

Authors:  Paul S Myles; Elizabeth Williamson; Justin Oakley; Andrew Forbes
Journal:  Trials       Date:  2014-11-29       Impact factor: 2.279

5.  Comparison of the 3 Different Injection Techniques Used in a Randomized Controlled Study Evaluating a Cross-Linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide (Cingal) for Osteoarthritis of the Knee: A Subgroup Analysis.

Authors:  Robert McCormack; Martin Lamontagne; Christopher Vannabouathong; Robert T Deakon; Etienne L Belzile
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2017-08-14

6.  Decision Making for Healthcare Resource Allocation: Joint v. Separate Decisions on Interacting Interventions.

Authors:  Helen Dakin; Alastair Gray
Journal:  Med Decis Making       Date:  2018-05       Impact factor: 2.583

Review 7.  The quality of subgroup analyses in chronic pain randomized controlled trials: a methodological review.

Authors:  Mahmood AminiLari; Vahid Ashoorian; Alexa Caldwell; Yasir Rahman; Robby Nieuwlaat; Jason W Busse; Lawrence Mbuagbaw
Journal:  Korean J Pain       Date:  2021-04-01

8.  Effectiveness of Enhanced Performance Feedback on Appropriate Use of Blood Transfusions: A Comparison of 2 Cluster Randomized Trials.

Authors:  Simon J Stanworth; Rebecca Walwyn; John Grant-Casey; Suzanne Hartley; Lauren Moreau; Fabiana Lorencatto; Jill Francis; Natalie Gould; Nick Swart; Megan Rowley; Steve Morris; Jeremy Grimshaw; Amanda Farrin; Robbie Foy
Journal:  JAMA Netw Open       Date:  2022-02-01

9.  L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial.

Authors:  Anna P Ralph; Govert Waramori; Gysje J Pontororing; Enny Kenangalem; Andri Wiguna; Emiliana Tjitra; Dina B Lolong; Tsin W Yeo; Mark D Chatfield; Retno K Soemanto; Ivan Bastian; Richard Lumb; Graeme P Maguire; John Eisman; Ric N Price; Peter S Morris; Paul M Kelly; Nicholas M Anstey
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

10.  The evaluation of enhanced feedback interventions to reduce unnecessary blood transfusions (AFFINITIE): protocol for two linked cluster randomised factorial controlled trials.

Authors:  Suzanne Hartley; Robbie Foy; Rebecca E A Walwyn; Robert Cicero; Amanda J Farrin; Jill J Francis; Fabiana Lorencatto; Natalie J Gould; John Grant-Casey; Jeremy M Grimshaw; Liz Glidewell; Susan Michie; Stephen Morris; Simon J Stanworth
Journal:  Implement Sci       Date:  2017-07-03       Impact factor: 7.327

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.